top of page

Heart Spark Tech

Heart Spark Tech LLC is a health technology company dedicated to revolutionizing cardio-oncology care with AI-powered solutions.

 

Our flagship product is an AI-driven clinical decision aid (CDA) that predicts cardiovascular risk in cancer patients and survivors, integrating seamlessly with electronic health records (EHRs), treatment planning software, and pre-treatment workflows.

 

 

Mission Statement

​

Heart Spark Tech’s mission is to bridge the gap between cardiology and oncology, ensuring that cancer patients receive comprehensive, personalized, and proactive cardiovascular care throughout their treatment journey.

​

Our AI-powered risk assessment tool enables early intervention, minimizes complications, reduces hospital admissions and emergency interventions, and enhances survivorship quality of life.

​

​

Value Proposition

​

* First-in-class AI-powered risk assessment tool for cancer patients.
* Predicts cardiotoxicity risk pre-treatment, enabling early intervention.
* Seamless integration into EHRs for real-time clinical decision support.
* Reduces hospital admissions and emergency cardiovascular interventions.
* Improves cancer survivors' quality of life by preventing long-term cardiac complications.

​

​

Target Customers

​

>10,000 Hematology/Oncology Physicians
 

>20,000 Cardiologists
 

>70 NCI-Designated Cancer Centers
 

Health Systems & Hospitals
 

Insurance Payers & Medicare/Medicaid

​

​

Product & Technology

​

AI-Powered Clinical Decision Aid (CDA)

  • Predicts cardiovascular risk in cancer patients before and during treatment.

  • Integrates with EHRs for real-time risk stratification.

  • Provides evidence-based recommendations.

​

​

Incorporating AI-Powered Cardiovascular Risk Assessment Throughout Cancer Journey

​

Heart Spark Tech follows a structured approach to integrate AI-powered cardiovascular care into every phase of the cancer treatment journey:

​

Phase 1: Prevention & Risk Assessment (Pre-Diagnosis)

Phase 2: Diagnosis & Treatment Planning

Phase 3: Active Treatment Phase

Phase 4: Post-Treatment & Survivorship

Phase 5: Palliative & End-of-Life Care

​

​

The Future of AI in Cardio-Oncology

​

Heart Spark Tech is poised to revolutionize cardio-oncology with AI-powered ECG-based cardiovascular risk assessment tools, enabling early intervention, personalized treatment plans, and improved patient outcomes.

​

* AI-driven cardiotoxicity prediction will set a new standard for cardio-oncology care.

* Seamless EHR integration will improve workflow efficiency and physician adoption.
* Reduction in hospital admissions and emergency interventions.
* Strategic partnerships with hospitals, payers, and pharma companies will ensure long-term sustainability.

​

With a clear roadmap, structured AI integration at every stage of cancer treatment, and an innovative approach to cardio-oncology, Heart Spark Tech is positioned for rapid growth, clinical impact, and global success in transforming cardiovascular care for cancer survivors.

My Heart Spark P.C.

My Heart Spark P.C. is a national innovative interprofessional consultation and telehealth medical practice specializing in cardiac preventive care, offering electronic and virtual services nationwide with a focus on preserving heart health, particularly for individuals who have ever been diagnosed with cancer.

 

The practice also collaborates with med spas to enhance wellness experiences.

 

To expand its services into technology development and licensing, My Heart Spark P.C. operates Heart Spark Tech as a "doing business as" (DBA) entity. This strategic move allows the organization to integrate technological innovations into its healthcare offerings, thereby enhancing patient care and engagement.

 

This expansion aligns with the organization's mission to provide comprehensive cardiac care, utilizing technological advancements to improve patient outcomes and experiences.

bottom of page